Al Lin
Impact in
- Hematology top 10%
- Erythropoietin and Anemia Treatment
- Nephrology top 10%
- Chronic Kidney Disease and Diabetes
- Acute Kidney Injury Research
Papers in
-
- Erythropoietin and Anemia Treatment 6
-
- Chronic Kidney Disease and Diabetes 1
- Co-authors
- Guangjie Guo (3 shared papers)Qingjian Wang (2 shared papers)Todd W. Seeley (2 shared papers)William R. Usinger (1 shared paper)Weihua Zhang (1 shared paper)Noëlynn Oliver (1 shared paper)Ingrid Langsetmo (2 shared papers)Ughetta del Balzo (3 shared papers)
- Journals
- Blood (3 papers)Journal of Pharmacology and Experimental Therapeutics (1 paper)PLoS ONE (1 paper)International Journal of Toxicology (1 paper)PubMed (1 paper)
- Partner nations
- United States
In The Last Decade
Al Lin
7 papers receiving 514 citations
Peers
Comparison fields: 5 of 53
- Hematology 135
- Nephrology 56
- Cancer Research 60
- Hepatology 24
- Pulmonary and Respiratory Medicine 61
Countries citing papers authored by Al Lin
This map shows the geographic impact of Al Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Al Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Al Lin more than expected).
Fields of papers citing papers by Al Lin
This network shows the impact of papers produced by Al Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Al Lin. The network helps show where Al Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Al Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 263 | |
| 2 | 2007 | 145 | |
| 3 | 2020 | 49 | |
| 4 | 2017 | 42 | |
| 5 | 2004 | 15 | |
| 6 | 2021 | 15 | |
| 7 | 2005 | 2 |
About Al Lin
Al Lin is a scholar working on Hematology, Nephrology, Cancer Research, Molecular Biology and Nuclear Energy and Engineering, having authored 7 papers that have together received 531 indexed citations. Recurring topics across this work include Erythropoietin and Anemia Treatment (6 papers), Chronic Kidney Disease and Diabetes (1 paper), Connective Tissue Growth Factor Research (1 paper) and Carcinogens and Genotoxicity Assessment (1 paper). The work is most often cited by research in Hematology (135 citations), Nephrology (56 citations), Cancer Research (60 citations), Hepatology (24 citations) and Pulmonary and Respiratory Medicine (61 citations). Al Lin has collaborated with scholars based in United States. Frequent co-authors include Guangjie Guo, Qingjian Wang, Todd W. Seeley, William R. Usinger, Weihua Zhang, Noëlynn Oliver, Ingrid Langsetmo, Ughetta del Balzo, Matthew M. Hsieh and Stephen J. Klaus. Their work appears in journals such as Blood, Journal of Pharmacology and Experimental Therapeutics, PLoS ONE, International Journal of Toxicology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.